References
- Raoult D, Marrie TJ, Mege JL. Natural history and pathophysiology of Q fever. Lancet Infect Dis 2005; 5: 219–26
- Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis 2000; 6: 601–8
- Janka G, Imashuku S, Elinder G, Schneider M, Henter JI. Infection- and malignancy- associated hemophagocytic syndromes. Hematol Oncol Clin North Am 1998; 12: 435–44
- Imashuku S. Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol 1997; 66: 135–51
- Favara BE. Hemophagocytic lymphohistiocytosis: a hemophagocytic syndrome. Semin Diag Pathol 1992; 9: 64–74
- Larroche C, Mouthon L. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmunity Rev 2004; 3: 69–75
- Estrov Z, Bruck R, Shtalrid M, Berrebi A, Resnitzky P. Histiocytic hemophagocytosis in Q fever. Arch Pathol Lab Med 1984; 108: 7
- Hufnagel M, Niemeyer C, Zimmerhackl LB, Tuchelmann T, Sauter S, Brandis M. Hemophagocytosis: a complication of acute Q fever in child. Clin Infect Dis 1995; 21: 1029–31
- Lee HC, Ko WC, Lee HL, Chen HY. Clinical manifestations and complications of rickttsiosis in southern Taiwan. J Formos Med Assoc 2002; 101: 385–92
- Ende N, Gelpi AP. Pathologic changes noted in bone marrow in a case of Q fever. Arch Intern Med 1957; 100: 793–5
- Delsol G, Pellegrin M, Familiades J, Auvergnat JC. Bone marrow lesions in Q fever. Blood 1978; 52: 637–8
- Srigley JR, Vellend H, Palmer N, Phillips MJ, Geddie WR, Van Nostrand AW, Edwards VD. Q fever. The liver and bone marrow pathology. Am J Surg Pathol 1985; 9: 752–8
- Cardellach F, Font J, Agusti AGN, Ingelmo M, Balcells A. Q fever and hemolytic anemia. J Infect Dis 1983; 148: 769
- Turck WPG, Howitt G, Turnberg LA, Fox H, Longson M, Matthews MB, Das Gupta R. Chronic Q fever. Q J Med 1976; 45: 193–217
- Honstettre A, Imbert G, Ghigo E, Gouriet F, Capo C, Raoult D, Mege JL. Dysregulation of cytokines in acute Q fever: role of interleukin-10 and tumor necrosis factor in chronic evolution of Q fever. J Infect Dis 2003; 187: 956–62
- Tyczka J, Maass W, Jager C, Menge C, Baljer G. Differences in cytokine mRNA profiles between naïve and in vivo-primed ovine PBMC after exposure to heat-inactivated Coxiella burnetii. Ann N Y Acad Sci 2003; 990: 460–7
- Sekigawa I, Suzuki J, Nawata M, Ikeda K, Koike M, Iida N, Hashimoto H, Oshimi K. Hemophagocytosis in autoimmune disease. Clin Exp Rheumatol 2001; 19: 333–8
- Ordi-Ros J, Selva-O'Callaghan A, Monegal-Ferran F, Monasterio-Aspiri Y, Juste-Sanchez C, Vilardell-Tarres M. Prevalence, significance, and specificity of antibodies to phospholipids in Q fever. Clin Infect Dis 1994; 18: 213–8
- Tolosa-Vilella C, Rodrihuez-Jornet A, Font-Rocabanyera J, Andreu-Navarro X. Mesangioproliferative glomerulonephritis and antibodies to phospholipids in a patient with acute Q fever: case report. Clin Infect Dis 1995; 21: 196–8
- Yeaman MR, Mitscher LA, Baca OG. In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones. Antimicrob Agents Chemother 1987; 31: 1079–84
- Yeaman MR, Roman MJ, Baca OG. Antibiotic susceptibility of two Coxiella burnetii isolates implicated in distinct clinical syndromes. Antimicrob Agents Chemother 1989; 33: 1052–7
- Andoh M, Naganawa T, Yamahuchi T, Fukushi H, Hirai K. In vitro susceptibility to tetracycline and fluoroquinolones of Japanese isolates of Coxiella burnetii. Microbiol Immunol 2004; 48: 661–4